PRFX · PRF Technologies Ltd. · Metrics
Market Cap
$2.75M
Shares
3.50M
Volume · Nov 12
273.37K
Avg daily vol (3M)
315.02K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
PRFX metrics
54 of 125 screener metrics currently available.
Market overview
2 metricsShare price
$0.79
Market cap
$2.75M
Price action
23 metricsPrice change (1W)
-2.8%
Price change (30D)
-9.1%
Price change (3M)
-27.8%
Price change (6M)
-53.8%
Price change (YTD)
—
Price change (1Y)
—
Trailing year
Price change (5Y)
—
52-week high
—
52-week low
—
Change from 52-week high
—
Change from 52-week low
—
Annualized volatility
194.8%
Annualized volatility (3M)
81.7%
Implied volatility (30D)
—
IV rank (1Y)
—
IV percentile (1Y)
—
Beta
2.4
RSI (14D)
43.5
Price vs SMA 50
-13.8%
Price vs SMA 200
—
Avg volume (3M)
312,041
Relative volume
0.1
Average dollar volume
$307,464
Company
3 metricsSector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Shares outstanding
3.50M
Valuation
12 metricsP / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
83.9×
reciprocal yield 1.2%
P / book
0.2
reciprocal yield 610.1%
FCF yield
-169.5%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-217.1%
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
—
Profitability
9 metricsGross margin
-306.5%
Operating margin
-17,077.4%
Trailing 12 months
Net margin
-18,219.4%
Gross profit (TTM)
−$95,000
Operating profit (TTM)
−$5.29M
Net income (TTM)
−$5.65M
Trailing 12 months
Diluted EPS (TTM)
—
FCF margin
-14,229.0%
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
—
Year over year
Net income growth YoY
—
Revenue (TTM)
$31,000
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+368.7%
Year over year · more shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
-35.6%
Return on assets
-29.6%
Debt / equity
—
Current ratio
5.1
EBITDA (TTM)
—
Free cash flow (TTM)
−$4.41M
Quick ratio
5.1
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$8.53M
Total assets
$19.09M
Total debt
—
Cash flow & spend
7 metricsOperating cash flow (TTM)
−$4.41M
Capital expenditures (TTM)
$4,000
R&D (TTM)
$1.66M
SG&A (TTM)
—
Stock compensation (TTM)
$89,000
R&D / revenue
5,367.7%
Stock compensation / revenue
287.1%
Ownership (13F)
9 metrics13F filers
8
13F filer change QoQ
+4
Institutional ownership
5.8%
Conviction holders (share of 13F filers)
—
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
+1,320.9%
Holder tenure
1.4
Price vs estimated holder cost
-29.7%
Ownership (registered funds)
1 metricsIndex-fund ownership
0.0%
Short interest
3 metricsShort interest
0.4%
Latest settlement · 1.0 days to cover
Days to cover
1.0d
Short-squeeze score
36 / 100
Insider activity
2 metricsNet insider buying (90D)
—
Insider-sentiment score
—
Risk flags
1 metricsGoing concern
—